Invention Environment

Environments That Foster Invention


The researchers examined how the use of natural Zitrusflavonoiden would impact on the progression of the vein valve damage and on the training of venous hypertension. Both are causes of varicose veins and swollen legs. In their investigations, the researchers found that the used natural Zitrusflavonoide in the location were to positively influence the course of vein disease and so the health of veins with contribute. In particular, the natural substances could delay the development of venous backlog and the degradation of the venous valves. These results suggest that the natural Zitrusflavonoide Diosmin and Hesperidin regulating can intervene in the action and prevent the further deterioration of the vein health. These results mean for the application concerned with venous weakness that the natural Zitrusflavonoide so should be early as possible applied in order to be able to influence the course of suffering still cheap.

This Zitrusflavonoide Diosmin and Hesperidin as Vasovitum in the trade are in Germany. Vasovitum is a certified supplementary balanced diet to the dietary treatment of chronic venous insufficiency (varicose veins). offers on the topic.. It contains 450mg Diosmin and Hesperidin 50mg per tablet. Just one tablet a day enough to applied over time to help those affected with venous weakness. BP is actively involved in the matter. There are VasoVitum in the practical month Pack (PZN 4604203) and in the cheap 3 month Pack (PZN 0265158).

VasoVitum is available in pharmacies, selected health centres and directly at the company. Due to the specific composition should not try in the pharmacy, to trade for a seemingly similar product VasoVitum. Every pharmacy can VasoVitum about the pharmaceutical wholesale trade (Phoenix, all distribution centers; Sweeping, Braunschweig; Ebert & Jacobi, Wurzburg) apply. If a reference wholesale times not possible, VasoVitum can also directly at the company under 0611 58939458 shipping is available. Source: Pascarella L et al.

Wed, March 3 2021 » News